[go: up one dir, main page]

GB1243832A - Vaccines - Google Patents

Vaccines

Info

Publication number
GB1243832A
GB1243832A GB5064568A GB5064568A GB1243832A GB 1243832 A GB1243832 A GB 1243832A GB 5064568 A GB5064568 A GB 5064568A GB 5064568 A GB5064568 A GB 5064568A GB 1243832 A GB1243832 A GB 1243832A
Authority
GB
United Kingdom
Prior art keywords
allergenic material
haloformate
oct
chloroformate
allergenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5064568A
Inventor
Brian George Overell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Priority to GB5064568A priority Critical patent/GB1243832A/en
Priority to IE143069A priority patent/IE33603B1/en
Priority to DK561269A priority patent/DK125308B/en
Priority to FR6936324A priority patent/FR2021556B1/fr
Priority to BE740801D priority patent/BE740801A/xx
Priority to ES372843A priority patent/ES372843A1/en
Priority to NL6916121A priority patent/NL6916121A/xx
Priority to AT1003869A priority patent/AT293617B/en
Priority to CH1589469A priority patent/CH536633A/en
Priority to DE19691953995 priority patent/DE1953995A1/en
Publication of GB1243832A publication Critical patent/GB1243832A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

1,243,832. Allergens. BEECHAM GROUP Ltd. 23 Oct., 1969 [25 Oct., 1968], No. 50645/ 68. Heading A5B. The allergenicity of an allergenic material is reduced by treating the allergenic material with a haloformate having the formula RO.CO.X wherein X is a halogen and R is alkyl, alkenyl, aryl, aralkyl, arylcarbonyl or a heterocyclic group, at a pH of from 1 to 7 and recovering the resultant modified allergenic material. The haloformate is preferably a chloroformate especially methyl, ethyl or benzoyl chloroformate. The temperature employed for the treatment is preferably about 20‹C. The allergenic material treated may be a protein or glycoprotein extract of the whole allergen. The allergenic material may be, or may be derived from, pollen. Pharmaceutical preparations for parenteral administration comprise the modified allergenic material and a parenterally acceptable carrier.
GB5064568A 1968-10-25 1968-10-25 Vaccines Expired GB1243832A (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GB5064568A GB1243832A (en) 1968-10-25 1968-10-25 Vaccines
IE143069A IE33603B1 (en) 1968-10-25 1969-10-20 Vaccines
DK561269A DK125308B (en) 1968-10-25 1969-10-23 Process for the preparation of a modified allergenic material.
FR6936324A FR2021556B1 (en) 1968-10-25 1969-10-23
BE740801D BE740801A (en) 1968-10-25 1969-10-24
ES372843A ES372843A1 (en) 1968-10-25 1969-10-24 Vaccines
NL6916121A NL6916121A (en) 1968-10-25 1969-10-24
AT1003869A AT293617B (en) 1968-10-25 1969-10-24 Process for the preparation of a modified allergen material for the treatment of allergic conditions
CH1589469A CH536633A (en) 1968-10-25 1969-10-25 Process for the production of modified allergen substances
DE19691953995 DE1953995A1 (en) 1968-10-25 1969-10-27 Allergy desensitizers and process for their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5064568A GB1243832A (en) 1968-10-25 1968-10-25 Vaccines

Publications (1)

Publication Number Publication Date
GB1243832A true GB1243832A (en) 1971-08-25

Family

ID=10456759

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5064568A Expired GB1243832A (en) 1968-10-25 1968-10-25 Vaccines

Country Status (10)

Country Link
AT (1) AT293617B (en)
BE (1) BE740801A (en)
CH (1) CH536633A (en)
DE (1) DE1953995A1 (en)
DK (1) DK125308B (en)
ES (1) ES372843A1 (en)
FR (1) FR2021556B1 (en)
GB (1) GB1243832A (en)
IE (1) IE33603B1 (en)
NL (1) NL6916121A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2178582B1 (en) * 2000-12-01 2003-11-01 Lozano Juan Jose Martin CUP PROFILE, FOR THE ASSEMBLY OF TWO FLOORS OF ELECTRIC PANELS.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1174854A (en) * 1967-07-07 1969-12-17 Miles Lab New Biologically Active Conjugates

Also Published As

Publication number Publication date
BE740801A (en) 1970-04-24
FR2021556B1 (en) 1973-01-12
FR2021556A1 (en) 1970-07-24
CH536633A (en) 1973-05-15
NL6916121A (en) 1970-04-28
AT293617B (en) 1971-10-25
IE33603L (en) 1970-04-25
DK125308B (en) 1973-02-05
IE33603B1 (en) 1974-08-21
ES372843A1 (en) 1971-11-01
DE1953995A1 (en) 1970-04-30

Similar Documents

Publication Publication Date Title
ATE182271T1 (en) MEDICINAL PRODUCTS FOR THE TREATMENT OF CANCER, AIDS AND VIRUS DISEASES
NL930121I1 (en) Process for the preparation of nonapeptide amide derivatives and pharmaceutical preparations with ovulation-stimulating effect therefrom
EP0726758A4 (en) Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
NL7607649A (en) PROCESS FOR PREPARING N- (3-TRIFLUORM-THYL 4-HALOGENOPHENYL) N'-BENZOYLUREA, AND PROCESS FOR PREPARING INSECTICIDE PREPARATIONS ON THE BASIS AND THEIR USE OF THEIR INJECTORS.
GB1183506A (en) New vaccines for combating influenza and the preparation thereof
OA09889A (en) Peptides for inducing-cytotoxic T-lymphocyte responses to hepatitis B virus.
NZ221379A (en) Nematode plasma membrane-associated protein, extraction method and vaccines containing it
ATE99953T1 (en) COMBINATION ANTIVIRAL MEDICATION.
DE3751772D1 (en) Vaccine for the treatment of HSV
GB1243832A (en) Vaccines
IL36329A (en) Vaccine for immunization of poultry against marek's disease
LU78951A1 (en) NEW VACCINE
BG52073B2 (en) Method for the preparation of recombinant human noncystein -interferon, free of n-end methionine
EP0299050A4 (en) Isolation of single chain proteins with fsh suppressing activity from follicular fluid.
Itil Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients.
NL7511023A (en) PROCESS FOR THE SEPARATION AND PURIFICATION OF (ALPHA) AMINO ACIDS FROM BY-PRODUCTS FORMED BY THE PREPARATION PROCEDURE.
GB1114683A (en) Process for purifying proteinaceous fractions from mistletoe by ultracentrifugation
ES353533A1 (en) Tetanus vaccine and process for preparing it
DE3783122D1 (en) USE OF RECOMBINED HUMAN ALPHA INTERFERON FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR TREATING THE AIDS VIRUS.
NL7609794A (en) TRIFLUORMETHYL CONTAINING ARALKYL ESTERS OF AMINO ACIDS, PHARMACEUTICAL PREPARATION AND METHODS FOR PREPARING THEM
GB1212886A (en) Equine vaccine and vaccination treatment
GB1434181A (en) Vaccine for the prevention and treatment of vascular conditions
NL7512384A (en) PROCEDURE FOR PREPARING 10.11-DIHYDRO 3-CARBOXYCYPROHEPTADINS.
NL7510068A (en) PROCEDURE FOR PREPARING ESTERS OF 5-N-BUTYL-PYRIDINECARBONIC ACID- (2), PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS USING THEREOF AND PREPARATIONS SUCH AS FORMED.
GB1108245A (en) A diuretic antitoxic and mental-stimulating extract of mammalian brain and a process for its production